Riskpilot← Back to searchSign inGet full accessKRS Dyreklinik ApS
APSActiveCVR 40651365Maribovej 90Veterinary activities · NACE 7500Est. 201929 employees
Revenue 2024
DKK 10,1M
+9% vs 2023
EBITDA margin
9.7%
+22% vs 2023
Equity ratio
31.3%
Financial strength
Net profit 2024
DKK 239K
+65% vs 2023
| Revenue | DKK 10,1M | +9% |
| EBITDA | DKK 974K | +22% |
| Net profit | DKK 239K | +65% |
| Total assets | DKK 6,4M | -3% |
| Equity | DKK 2M | +14% |
| Employees | 29 | — |
Legal name
KRS Dyreklinik ApS
CVR number
40651365
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
5. juli 2019
Share capital
DKK 750.000
Employees
29 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsens formand eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive dyreklinik, at eje anparter i datterselskaber og hermed beslægtede virksomheder.
Address
Maribovej 90
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7.175 | 9.280 | 9.397 | 9.258 | 10.059 |
| Staff expenses | -6.326 | -8.174 | -8.396 | -8.460 | -8.989 |
| EBITDA | 849 | 1.103 | 1.000 | 799 | 974 |
| Depreciation & amort. | -422 | -460 | -466 | -448 | -475 |
| EBIT | 427 | 643 | 534 | 351 | 498 |
| Net financials | -211 | -160 | -115 | -164 | -193 |
| Profit before tax | 216 | 484 | 419 | 187 | 306 |
| Tax | 52 | 109 | 92 | 43 | 67 |
| Net profit | 164 | 375 | 327 | 144 | 239 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5.915 | 5.475 | 5.602 | 6.579 | 6.395 |
| Equity | 914 | 1.288 | 1.615 | 1.760 | 1.999 |
| Long-term debt | 3.353 | 2.239 | 2.047 | 1.512 | 2.258 |
| Short-term debt | 1.598 | 1.891 | 1.876 | 3.220 | 2.062 |
| Total debt | 4.950 | 4.130 | 3.923 | 4.732 | 4.320 |
EBITDA margin
9.7%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
31.3%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
12.0%
This company
18.4%
Market median
+35% vs market
20202024
Net profit margin
2.4%
This company
8.1%
Market median
-70% vs market
20202024
Asset turnover
1.57×
This company
1.12×
Market median
+40% vs market
20202024
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-07-05 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SF Management | Management | 2019 | — | — |
RE Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Errebo Klausen Holding ApS | Company | 33.3% | 33.3% | 2019 |
KKH Holding 2019 ApS | Company | 33.3% | 33.3% | 2019 |
SFS Holding 2019 ApS | Company | 33.3% | 33.3% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KKH Holding 2019 ApS
KRS Dyreklinik ApS Board members of KRS Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sisse From Stage | Management | 0 companies |
| Rikke Errebo Klausen | Management | 0 companies |
| Karen Hansen | Chairman | 0 companies |